Department of Endocrinology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
Guangdong Clinical Research Center for Metabolic Diseases, Guangzhou Key Laboratory for Metabolic Diseases, Guangzhou, China.
Clin Cardiol. 2024 Oct;47(10):e70020. doi: 10.1002/clc.70020.
Obesity/overweight and metabolic anomalies are known to be associated with elevated cardiovascular disease (CVD) risk. However, there is a paucity of research exploring the association between different body weights, varying metabolic statuses, and the occurrence of CVD in the Chinese population. Thus, we performed this study to explore the relation between different metabolic overweight/obesity phenotypes and the prevalence of CVD.
We analyzed data from 9075 participants in the Risk Evaluation of cAncers in Chinese diabeTic Individuals: A lONgitudinal (REACTION) study. Participants were classified into four metabolic phenotypes based on their metabolic status and obesity/overweight status. Regression analysis was used to evaluate the relationship between CVD and different groups. Additionally, we conducted a subgroup analysis to further explore the relationship between CVD and different metabolic abnormalities.
Compared to metabolically healthy non-overweight/obesity (MHNO) individuals, both overweight/obesity and metabolic anomalies were positively associated with CVD prevalence. Among other metabolically unhealthy and overweight/obesity phenotypes, metabolically healthy overweight/obesity (MHO) generally exhibited a comparatively lower association with CVD. In the elderly, high waist circumference was significantly associated with CVD, rather than body weight. Further analysis revealed that hypertension had the strongest association with CVD.
Elderly individuals should place more emphasis on managing their waist circumference rather than only on BMI. CVD prevention should focus on both body weight management and treatment of metabolic diseases, with particular emphasis on antihypertensive therapy.
肥胖/超重和代谢异常与心血管疾病(CVD)风险升高有关。然而,对于不同体重、不同代谢状态与 CVD 发生之间的关系,在中国人中研究甚少。因此,我们进行了这项研究,以探讨不同的代谢超重/肥胖表型与 CVD 患病率之间的关系。
我们分析了来自中国糖尿病个体癌症风险评估:纵向研究(REACTION)中的 9075 名参与者的数据。根据代谢状态和肥胖/超重状态,将参与者分为四种代谢表型。回归分析用于评估 CVD 与不同组之间的关系。此外,我们进行了亚组分析,以进一步探讨 CVD 与不同代谢异常之间的关系。
与代谢健康非超重/肥胖(MHNO)个体相比,超重/肥胖和代谢异常均与 CVD 患病率呈正相关。在其他代谢不健康和超重/肥胖表型中,代谢健康超重/肥胖(MHO)与 CVD 的相关性通常较低。在老年人中,高腰围与 CVD 显著相关,而不是体重。进一步分析显示,高血压与 CVD 的相关性最强。
老年人应更加重视管理腰围,而不仅仅是 BMI。CVD 预防应同时关注体重管理和代谢性疾病的治疗,特别强调降压治疗。